Heparin therapy studied for prophylaxis use
Heparin therapy studied for prophylaxis use
The risk of venous thromboembolism in patients undergoing total hip replacement is high. A study of patients who’d had the procedure concluded that thromboembolism of deep veins is less likely when low-molecular-weight heparin (enoxaparin) is administered for a month following surgery.1 Typically it is administered only during hospitalization. How to do that outside the hospital? Most patients, say the investigators, can self-inject the agent at home when motivated to do so.
Reference
1. Bergqvist D, Benoni G, Bjorgell O, et al. Low-molecular weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335:696-700.
Andrea Rogers, RN, unit manager of the cardiovascular intensive care unit at Carondolet St. Mary’s Hospital in Tucson, AZ. Telephone: (520) 622-5833.
Jeanne Sandecki, RN, quality improvement coordinator at Promina-Gwinnett Health System in Lawrenceville, GA. Telephone: (770) 995-4667.
Laura Sauerbeck, clinical research coordinator, The Greater Cincinnati-Northern Kentucky Stroke Research Center, Cincinnati. Telephone: (513) 558-1742.
Patricia Mahoney, RN, coordinator of emergency services at Richmond (VA) Memorial Hospital. Telephone: (804) 254-6300.
Carolyn Brown, RN, MN, CCRN, cardiology clinical coordinator, Emory University Hospital in Atlanta. Telephone: (404) 712-4368.
Mary Welch, RN, MSN, cardiovascular case manager at Moses H. Cone Memorial Hospital, Greensboro, NC. Telephone: (910) 574-8027.
Lisa Kiger, RN, MSN, CCRN, clinical nurse specialist, cardiology, North Carolina Baptist Hospitals, Winston-Salem, NC. Telephone: (910) 716-6238.
Carol Maller, MS, RN, CHES, patient education coordinator, VA Medical Center in Albuquerque, NM. Telephone: (505) 265-1711, ext. 4656.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.